Pricing Log in Create free account
Friday 6 November 2026 Export CAI’s income statement to Excel — free account

Caris Life Sciences,�Inc.

CAI Healthcare Biotechnology

Caris Life Sciences,�Inc.’s revenue for fiscal 2025 (year ended December 2025) was $812.0 million, up 97.0% from fiscal 2024.

Revenue
+27.0%
EPS
−40.3%
Free cash flow
−140.2%
Total debt
+4.46%

Quarter to September 2026, against a year earlier

25.11 0.92 −3.53%
Market cap
$7.4B
P/E
73.9×
Fwd P/E
254×
Dividend yield
—
F-score
n/a
Altman Z
3.55
Beneish M
−2.71
Dividend safety
n/a
Overview Business Profile Earnings & Analysis
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios
Segments Valuation Filings

Caris Life Sciences,�Inc. (CAI) EV/Sales

Alert me on EV/Sales

As of 6 November 2026, Caris Life Sciences,�Inc. (CAI) trades at a EV/Sales of 6.4×. Over the past ten years it has ranged from 0.0× (June 2025) to 14.4× (October 2025); the current reading is higher than 56% of that period. That is below the Biotechnology industry median of 9.0× and above the Healthcare sector median of 3.6×.

EV/Sales, daily

Embed this chart

Annual newest first

Period EV/Sales Change
FY2025 8.9× —
FY2024 0.0× —
FY2023 0.0× —

Quarterly newest first

Period EV/Sales Change
Sep 2026 7.9× 69.29%
Jun 2026 4.7× (7.70%)
Mar 2026 5.1× (42.64%)
Dec 2025 8.9× (32.55%)
5 more quarters

Against its own ten years

Low 0.0× High 14.4×
Ten-year median 6.0×
Current reading's percentile 56

EV/Sales against peers

Company EV/Sales
ABVX Abivax SA Sponsored ADR compare n/m
CAI Caris Life Sciences,�Inc. 6.4×
CORT Corcept Therapeutics Incorporated compare 7.7×
AXSM Axsome Therapeutics, Inc. compare 7.8×
ARWR Arrowhead Pharmaceuticals, Inc. compare 11.3×
TWST Twist Bioscience Corporation compare 16.9×
RYTM Rhythm Pharmaceuticals, Inc. compare 26.5×
CYTK Cytokinetics, Incorporated compare 66.3×
PRAX Praxis Precision Medicines, Inc. compare 854×
Biotechnology industry median 9.0×
Healthcare sector median 3.6×
Market median 2.1×

What EV/Sales is

EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)

The full definition of EV/Sales →

More on CAI